Pulmonary arterial hypertension-associated changes in gut pathology and microbiota

Ravindra K. Sharma, Aline C. Oliveira, Tao Yang, Seungbum Kim, Jasenka Zubcevic, Victor Aquino, Gilberto O. Lobaton, Ruby Goel, Elaine M. Richards, Mohan K. Raizada

Source: ERJ Open Res, 6 (3) 00253-2019; 10.1183/23120541.00253-2019
Journal Issue: July
Disease area: Pulmonary vascular diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Ravindra K. Sharma, Aline C. Oliveira, Tao Yang, Seungbum Kim, Jasenka Zubcevic, Victor Aquino, Gilberto O. Lobaton, Ruby Goel, Elaine M. Richards, Mohan K. Raizada. Pulmonary arterial hypertension-associated changes in gut pathology and microbiota. ERJ Open Res, 6 (3) 00253-2019; 10.1183/23120541.00253-2019

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Altered gut microbiota in chronic thromboembolic pulmonary hypertension
Source: Virtual Congress 2021 – Pathogenesis and pathophysiology of pulmonary hypertension
Year: 2021


Arterial vascular volume changes with haemodynamics in schistosomiasis-associated pulmonary arterial hypertension
Source: Eur Respir J, 57 (5) 2003914; 10.1183/13993003.03914-2020
Year: 2021



Inflammatory mediators contribute to pulmonary arterial cell dysfunction in a pulmonary arterial hypertension patient with BMPR2 mutation
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I
Year: 2013

The Role of Inflammation in promoting pulmonary hypertension in idiopatchi and connective tissue disease-associated PAH
Source: Research Seminar 2008 - The Pulmonary Circulation: Scleroderma-Related Pulmonary Arterial Hypertension
Year: 2008


Late Breaking Abstract - The effect of altering gut microbiota on the development of pulmonary hypertension
Source: International Congress 2019 – Pulmonary hypertension: new therapeutic pathways and modalities
Year: 2019


Gene expression alterations in mice lacking the VIP gene are conducive to pulmonary arterial hypertension and pulmonary vascular remodeling
Source: Annual Congress 2007 - Cellular and molecular aspects of pulmonary hypertension
Year: 2007


Pulmonary arterial hypertension (PAH) in mice lacking the vasoactive intestinal polypeptide (VIP) gene: morphometric evidence for vascular remodeling
Source: Annual Congress 2006 - Signalisation in the pulmonary vasculature: new pathways and wrong signals
Year: 2006


LSC 2014 abstract - Combined effects of inflammatory mediators and BMPR2 mutation on pulmonary arterial cell function in a pulmonary arterial hypertension
Source: International Congress 2014 – Pulmonary hypertension: pathobiology
Year: 2014

Impact on survival of pulmonary function abnormalities in pulmonary arterial hypertension
Source: Annual Congress 2009 - Pulmonary hypertension
Year: 2009

Veno-occlussive lesions and inflammation in pulmonary arterial hypertension associated with connective tissue diseases
Source: Annual Congress 2007 - Pulmonary hypertension in the clinic
Year: 2007


Involvement of CFTR in the pathogenesis of pulmonary arterial hypertension
Source: Eur Respir J, 58 (5) 2000653; 10.1183/13993003.00653-2020
Year: 2021



BMPR2 mutation status influences bronchial vascular changes in pulmonary arterial hypertension
Source: Eur Respir J 2016; 48: 1668-1681
Year: 2016



The emerging role of the contractile and vascular reserves in pulmonary arterial hypertension
Source: Eur Respir J 2015; 45: 1758-1759
Year: 2015


The emerging role of the contractile and vascular reserves in pulmonary arterial hypertension
Source: Eur Respir J 2015; 45: 1756-1758
Year: 2015


Endothelial NO and its pathophysiologic regulation
Source: Annual Congress 2007 - Role of the endothelium in pulmonary function and disease
Year: 2007


Pulmonary vascular disease
Source: HERMES Summer School 2014 - Educational material
Year: 2014

CFTR involvement in the pathogenesis of pulmonary arterial hypertension
Source: Virtual Congress 2020 – Experimental approaches to pulmonary hypertension
Year: 2020


The evolution of effort tolerance and body composition in patients with idiopathic pulmonary arterial hypertension
Source: International Congress 2014 – Chronic thromboembolic pulmonary hypertension
Year: 2014

Pulmonary vascular distensibility in pulmonary hypertension due to left heart disease
Source: International Congress 2018 – Pulmonary hypertension: right ventricle function, haemodynamics and exercise
Year: 2018